University of Texas PDX Development and Trial Center Grant
Demographics (3)
- AGE - Subject age at enrollment (phv00429965.v2.p1)
- SEX - Self-reported sex (phv00429963.v2.p1)
- SEX - Self-reported sex (phv00495401.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00429964.v2.p1)
Other (24)
- AFFECTION_STATUS - Case control status of the subject for lung cancer (phv00429962.v2.p1)
- AGE_ONSET - Disease onset age (phv00429966.v2.p1)
- ANALYTE_TYPE - Analyte Type (phv00429974.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00429972.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00429958.v2.p1)
- EGFR - Somatic mutation in EGFR (Entrez GeneID: 1956) (phv00429969.v2.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00429982.v2.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00429976.v2.p1)
- IS_TUMOR - Tumor status (phv00429975.v2.p1)
- KRAS - Somatic mutation in KRAS (Entrez GeneID: 3845) (phv00429967.v2.p1)
- PDX_Passage - PDX Passage (phv00429973.v2.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00429977.v2.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00429978.v2.p1)
- SAMPLE_ID - Sample ID (phv00429971.v2.p1)
- SAMPLE_ID - Sample ID (phv00429960.v2.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00429983.v2.p1)
- STK11 - Somatic mutation in STK11 (Entrez GeneID: 6794) (phv00429970.v2.p1)
- SUBJECT_ID - Subject ID (phv00429961.v2.p1)
- SUBJECT_ID - Subject ID (phv00429957.v2.p1)
- SUBJECT_ID - Subject ID (phv00429959.v2.p1)
- TP53 - Somatic mutation in TP53 (Entrez GeneID: 7157) (phv00429968.v2.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00429980.v2.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00429979.v2.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00429981.v2.p1)